Anfield Capital Management’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CCM
GCM
RIM
KCM
SCA
Anfield Capital Management's LMAT Position: Q4 2021 in Review
Anfield Capital Management sold out of LeMaitre Vascular (LMAT) in Q4 2021, closing a stake of 11 shares — an estimated $1K sold.
Anfield Capital Management first reported a position in LMAT in Q3 2021 and held it in 1 quarter. The position peaked at $1K in Q3 2021. 183 funds tracked by Wall St. Rank hold LMAT as of Q4 2021.
- Anfield Capital Management reported no remaining LeMaitre Vascular position as of Q4 2021 after selling out during the quarter.
- Anfield Capital Management sold 11 LeMaitre Vascular shares in Q4 2021, an estimated $1K.
- Anfield Capital Management first reported a position in LeMaitre Vascular in Q3 2021 and held it in 1 quarter.
- Anfield Capital Management's LeMaitre Vascular position peaked at $1K in Q3 2021.
- 183 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2021.
Based on Anfield Capital Management's 13F filing for Q4 2021, filed 3 Feb 2022.